Synchronous yet distinct HPV-associated sinonasal carcinomas on an immune-dysfunctional background.

J Surg Case Rep

Department of Otolaryngology-Head and Neck Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 500 Hofstra University, Hempstead, NY 11549, United States.

Published: September 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Human papillomavirus (HPV)-associated multiphenotypic sinonasal carcinoma (HMSC) is a relatively new classification of head and neck carcinomas that displays histological combinations of multiple different neoplasms. Despite their high-grade appearance, the disease course is often indolent. Here, we report a unique case of HMSC in which a patient with a prior history of sarcoidosis presented with two histologically, and anatomically distinct tumors in the sinonasal tract. One of the tumors was denoted as HMSC, and the other resembled a nonkeratinizing squamous cell carcinoma. Importantly, these two tumors were both found to be driven by the same high-risk HPV strain, HPV45, which has not been reported previously in HMSC. In this patient, it is important to note that the concomitant diagnosis of malignancy and sarcoidosis makes disease monitoring challenging, given the ability of sarcoidotic nodules to mimic the metabolic characteristics of tumors on PET scans.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401870PMC
http://dx.doi.org/10.1093/jscr/rjaf693DOI Listing

Publication Analysis

Top Keywords

hmsc patient
8
synchronous distinct
4
distinct hpv-associated
4
hpv-associated sinonasal
4
sinonasal carcinomas
4
carcinomas immune-dysfunctional
4
immune-dysfunctional background
4
background human
4
human papillomavirus
4
papillomavirus hpv-associated
4

Similar Publications

Synchronous yet distinct HPV-associated sinonasal carcinomas on an immune-dysfunctional background.

J Surg Case Rep

September 2025

Department of Otolaryngology-Head and Neck Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 500 Hofstra University, Hempstead, NY 11549, United States.

Human papillomavirus (HPV)-associated multiphenotypic sinonasal carcinoma (HMSC) is a relatively new classification of head and neck carcinomas that displays histological combinations of multiple different neoplasms. Despite their high-grade appearance, the disease course is often indolent. Here, we report a unique case of HMSC in which a patient with a prior history of sarcoidosis presented with two histologically, and anatomically distinct tumors in the sinonasal tract.

View Article and Find Full Text PDF

Background: Neuroinflammation contributes to Parkinson's disease (PD) progression and motor dysfunction. Allogeneic human mesenchymal stem cells (allo-hMSCs) may reduce neuroinflammation and improve motor symptoms.

Objectives: To evaluate the efficacy of repeated intravenous doses of 10 × 10/kg allo-hMSCs in improving motor symptoms in patients with PD (PwP).

View Article and Find Full Text PDF

Purpose: This study aimed to perform a systematic review of the clinicopathological, prognostic features, and HPV genotyping patterns of HPV-related multiphenotypic sinonasal carcinoma (HMSC).

Methods: This study adhered to the PRISMA 2020 guidelines and was registered in the PROSPERO database. We included case reports, case series studies, and cohort studies of HMSC indexed in the PubMed, Web of Science, Scopus, Embase, and LILACS databases published between 2017 and 2025.

View Article and Find Full Text PDF

Human papillomavirus-related multiphenotypic sinonasal carcinoma (HMSC) is a rare sinonasal tract tumor. Although HMSC has a favorable prognosis, patients tend to experience local recurrence after the initial therapy; therefore, careful follow-up is required after surgical dissection. Proton beam therapy is one of the therapeutic modalities used to treat sinonasal cancer.

View Article and Find Full Text PDF

Osteoarthritis (OA) is a degenerative joint condition leading to disability. The lack of effective treatment for OA creates a need for the development of new therapeutic approaches that may rely on stem cells including mesenchymal stem/stromal cells (MSCs) and their derivatives such as extracellular vesicles (EVs). The objective of this study was to evaluate the impact of MSCs derived from adipose tissue (AT-MSCs) and umbilical cord (UC-MSCs) and their EVs on cartilage-bone injury in vivo, to identify the specimen with the highest regenerative potential for further clinical applications in patients with OA.

View Article and Find Full Text PDF